Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Change in Accured Expenses (2016 - 2026)

Gyre Therapeutics has reported Change in Accured Expenses over the past 16 years, most recently at $2.4 million for Q4 2025.

  • Quarterly Change in Accured Expenses rose 13.98% to $2.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $946000.0 through Dec 2025, up 163.19% year-over-year, with the annual reading at $946000.0 for FY2025, 163.19% up from the prior year.
  • Change in Accured Expenses was $2.4 million for Q4 2025 at Gyre Therapeutics, up from -$3.5 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $6.2 million in Q4 2022 and troughed at -$5.2 million in Q4 2021.
  • The 5-year median for Change in Accured Expenses is $331500.0 (2021), against an average of -$43550.0.
  • Year-over-year, Change in Accured Expenses surged 3441.94% in 2022 and then tumbled 3275.71% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$5.2 million in 2021, then skyrocketed by 220.92% to $6.2 million in 2022, then crashed by 76.06% to $1.5 million in 2023, then surged by 39.95% to $2.1 million in 2024, then increased by 13.98% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Change in Accured Expenses are $2.4 million (Q4 2025), -$3.5 million (Q3 2025), and -$2.4 million (Q2 2025).